When #OSUCOM researcher Dr. John Byrd first began research into treatments for chronic lymphocytic leukemia in 1991, a CLL diagnosis was like a...

URL: https://www.facebook.com/OhioStateMed/posts/2355804471110211

Description

When #OSUCOM researcher Dr. John Byrd first began research into treatments for chronic lymphocytic leukemia in 1991, a CLL diagnosis was like a death sentence. Just nine years later, he published evidence of the first-ever treatment to prolong survival in patients with CLL, combining a newer, immune-based drug called rituximab with chemotherapy. http://go.osu.edu/Crwv

Content

When #OSUCOM researcher Dr. John Byrd first began research into treatments for chronic lymphocytic leukemia in 1991, a CLL diagnosis was like a death sentence. Just nine years later, he published evidence of the first-ever treatment to prolong survival in patients with CLL, combining a newer, immune-based drug called rituximab with chemotherapy. http://go.osu.edu/Crwv

Item Information

Content type: Facebook Page
Published: Thursday, Mar. 14 2019, 12:53pm
Imported: Thursday, Mar. 14 2019, 1:53pm
Channel: Ohio State University College of Medicine
Entity: College of Medicine

Tags

osucom

Keywords

college-medicine